Department of Neuropsychiatry, Kochi Medical School Kochi University, Nankoku, Kochi, Japan.
Nishi-Harima Dementia-Related Disease Medical Center, Hyogo Prefectural Rehabilitation Hospital at Nishi-Harima, Tatsuno, Hyogo, Japan.
Int J Geriatr Psychiatry. 2021 Jul;36(7):1103-1109. doi: 10.1002/gps.5527. Epub 2021 Mar 10.
Olfactory dysfunction is common in patients with mild cognitive impairment (MCI) or Alzheimer's disease (AD). We sought to elucidate brain regions associated with olfactory dysfunction in patients with MCI and early AD by using 123I-IMP-SPECT to detect regional cerebral blood flow (CBF).
We included 218 patients diagnosed with AD or MCI, who underwent a comprehensive battery of neuropsychiatric and neuropsychological tests, Alzheimer's Disease Assessment Scale-Cognitive Part (ADAS-Cog), and forward- and backward-digit span. Olfactory function was assessed using T&T olfactometry of five odors; patients stated whether they experienced any smell (detection test) and identified the odor (identification test). The association between single-photon emission computerized tomography based regional CBF and olfactory function was examined by voxel-by-voxel multiple regression analysis, considering sex, age, and education as covariate parameters.
Of the 218 patients, 78 had mildly impaired olfactory detection and 15 had olfactory detection loss; additionally, 213 had mild olfactory identification impairment. The odor detection score correlated significantly with the ADAS-Cog word recall score (r = 0.193, p = 0.004). The odor identification score correlated significantly with the ADAS memory (r = 0.408, p < 0.001) and ADAS orientation (r = 0.292, p < 0.001) scores. The odor identification score correlated negatively with CBF in the left temporal pole, entorhinal area, and bilateral frontal poles (p < 0.001).
Olfactory identification dysfunction in patients with MCI and AD is attributable to reduced CBF of the left temporal pole, entorhinal area, and bilateral frontal pole.
嗅觉功能障碍在轻度认知障碍(MCI)或阿尔茨海默病(AD)患者中很常见。我们试图通过使用 123I-IMP-SPECT 检测局部脑血流(CBF)来阐明与 MCI 和早期 AD 患者嗅觉功能障碍相关的脑区。
我们纳入了 218 名被诊断为 AD 或 MCI 的患者,他们接受了全面的神经精神和神经心理学测试、阿尔茨海默病评估量表-认知部分(ADAS-Cog)以及顺向和逆向数字跨度测试。使用 T&T 嗅觉仪对 5 种气味进行嗅觉功能评估;患者需要陈述是否闻到任何气味(检测测试)并识别气味(识别测试)。通过体素到体素的多元回归分析,考虑性别、年龄和教育作为协变量参数,检查基于单光子发射计算机化断层扫描的局部 CBF 与嗅觉功能之间的关联。
在 218 名患者中,78 名患者嗅觉检测轻度受损,15 名患者嗅觉检测丧失;此外,213 名患者嗅觉识别轻度受损。气味检测评分与 ADAS-Cog 单词回忆评分显著相关(r=0.193,p=0.004)。气味识别评分与 ADAS 记忆(r=0.408,p<0.001)和 ADAS 定向(r=0.292,p<0.001)评分显著相关。气味识别评分与左侧颞极、内嗅区和双侧额叶的 CBF 呈负相关(p<0.001)。
MCI 和 AD 患者的嗅觉识别功能障碍归因于左侧颞极、内嗅区和双侧额叶的 CBF 减少。